🇺🇸 FDA
Patent

US 8143295

Compounds having activity in correcting mutant-CFTR processing and uses thereof

granted A61KA61K31/00A61K31/428

Quick answer

US patent 8143295 (Compounds having activity in correcting mutant-CFTR processing and uses thereof) held by The Regents of the University of California expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/00, A61K31/428, A61K31/47, A61K31/517